• About Us
  • Advertise
  • Contact Us
  • DMCA
  • Follow on Google News
Friday, May 30, 2025
  • Login
National Age
  • Home
  • India
    • National
    • State News
  • World
  • Education
  • Lifestyle
    • Health & Fitness
    • Fashion
    • Travel
    • Food
  • Business
  • Tech
    • App News
    • Gadgets
  • Entertainment
  • Auto
  • Sports
  • Others
    • Agriculture
    • Science
    • Astrology
    • Finance/Money
    • Press Release
No Result
View All Result
  • Home
  • India
    • National
    • State News
  • World
  • Education
  • Lifestyle
    • Health & Fitness
    • Fashion
    • Travel
    • Food
  • Business
  • Tech
    • App News
    • Gadgets
  • Entertainment
  • Auto
  • Sports
  • Others
    • Agriculture
    • Science
    • Astrology
    • Finance/Money
    • Press Release
No Result
View All Result
National Age
No Result
View All Result
Home Lifestyle Health & Fitness

AustralaSian COVID-19 Trial opens in India

National Age by National Age
March 1, 2021
in Health & Fitness, National
0
Share on FacebookShare on Twitter

New Delhi: AustralaSian COVID-19 Trial (ASCOT) has been expanded into India, with the first patients recruited last week to the first two sites, Christian Medical College and Hospital Ludhiana in Punjab and Sterling Multispecialty Hospital in Pune, Maharashtra. Australasia is a region that comprises Australia, New Zealand, and some neighboring islands.

ASCOT has partnered with the George Institute for Global Health to oversee the trial in India given its substantial experience operating clinical trials in the country with a presence in 21 states.George Institute for Global Health is an independent medical research institute headquartered in Australia with offices in China, India and the United Kingdom.

ASCOT aims to discover which existing treatments are most effective in patients hospitalised with COVID-19 and whether they will prevent patients deteriorating to the point of needing a ventilator in the Intensive Care Unit.

Read ThisAlso

Combining NDT and DMI: A Comprehensive Approach to Developmental Delay

Combining NDT and DMI: A Comprehensive Approach to Developmental Delay

May 28, 2025
As COVID-19 Cases Resurface, Pravek Kalp Promotes Ayurvedic Immunity and Heart Health with Ashwagandha and Arjuna Capsules

As COVID-19 Cases Resurface, Pravek Kalp Promotes Ayurvedic Immunity and Heart Health with Ashwagandha and Arjuna Capsules

May 27, 2025

ASCOT has partnered with the George Institute for Global Health to oversee the trial in India given its substantial experience operating clinical trials in the country with a presence in 21 states.

ASCOT Principal Investigator, Associate Professor Steven Tong, a Royal Melbourne Hospital infectious diseases clinician and co-lead of clinical research at the Doherty Institute said that while ASCOT began as an Australian and New Zealand trial, expanding internationally to allow more widespread access to investigational treatments was crucial.

“A key principle of the trial is equity in terms of access to experimental treatments that could potentially have benefits for patients,” Associate Professor Tong said.

“The ASCOT Management Team and Leadership Group recognised early in the course of the trial that for it to have generalisability, external validity and be adequately powered, it would need to be expanded to international sites.”

India, like many other middle and low-income countries, is facing a severe epidemic of COVID-19. The number of patients with COVID-19 in India remains significantly higher than in Australia and New Zealand, and access to experimental treatments is limited.

Bala Venkatesh, Professorial Fellow at the George Institute for Global Health, said that while there are other ongoing clinical trials in India for COVID-19, the novel combinations of treatments included in ASCOT will provide greater opportunities to patients for accessing new treatments.

“We are confident that the study questions being asked are of priority to Indian patients and participating trial sites, and feasible to address in India,” said Professor Venkatesh.

One new treatment that’s recently been added to ASCOT is Nafamostat, which in laboratory experiments has shown to block SARS-COV-2 from entering human cells and be far more potent than Remdesivir.

“Nafamostat is mainly used in Korea and Japan as a treatment for acute pancreatitis and some blood clotting conditions. Of all drugs with potency data from laboratory studies using human cell lines, nafamostat appears to be the most potent against SARS-CoV-2 and maybe the only drug where blood concentrations almost always exceed levels required to stop the virus from replicating,” explained Associate Professor Tong.

“It is also likely that Nafamostat will reach high levels in the lungs where the SARS-CoV-2 virus causes so much of its problems. What’s more, it has a favourable safety profile.”

The ASCOT Steering Committee recently made the decision to cease enrolment into the convalescent plasma arm of the trial following a media release issued by the UK’s RECOVERY trial, which reported no benefit to patients compared with standard of care. (India Science Wire)

Tags: ASCOTAustralaSianChristian Medical College and HospitalClinical TrialCOVID-19Sterling Multispecialty Hospital
Share6Tweet4Share1SendShareSend
Previous Post

Dr. Harsh Vardhan dedicates two new databases to the nation

Next Post

Synthesis of agonist molecule by CSIR-IICT for COVAXIN

National Age

National Age

Related Posts

Combining NDT and DMI: A Comprehensive Approach to Developmental Delay
Health & Fitness

Combining NDT and DMI: A Comprehensive Approach to Developmental Delay

May 28, 2025
As COVID-19 Cases Resurface, Pravek Kalp Promotes Ayurvedic Immunity and Heart Health with Ashwagandha and Arjuna Capsules
Health & Fitness

As COVID-19 Cases Resurface, Pravek Kalp Promotes Ayurvedic Immunity and Heart Health with Ashwagandha and Arjuna Capsules

May 27, 2025
Global aesthetic thought leader shares innovations at milestone SIME 2025 event in Italy
Health & Fitness

Global aesthetic thought leader shares innovations at milestone SIME 2025 event in Italy

May 23, 2025
Aarogyaa Bharat: The Pune-Based Startup Revolutionizing Access to Medical Equipment Across India
Health & Fitness

Aarogyaa Bharat: The Pune-Based Startup Revolutionizing Access to Medical Equipment Across India

May 21, 2025
Invisalign Treatment Delivers Predictable Results for Adult Patients, Achieving Complete Space Closure in as Little as 8 Months
Health & Fitness

Invisalign Treatment Delivers Predictable Results for Adult Patients, Achieving Complete Space Closure in as Little as 8 Months

May 20, 2025
Dr. Vikas Sharma (LaghaV) – Winner of the 21st Century Emily Dickinson Award
Health & Fitness

Dr. Vikas Sharma (LaghaV) – Winner of the 21st Century Emily Dickinson Award

May 17, 2025
Next Post

Synthesis of agonist molecule by CSIR-IICT for COVAXIN

Sublethal exposure study of lead (Pb) on black clams to provide early warning information on marine pollution

“Data and Artificial Intelligence are growing sectors among new job clusters”

“Data and Artificial Intelligence are growing sectors among new job clusters”

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • Trending
  • Comments
  • Latest
Pro Cricket Championship Trophy (PCCT) announced the schedule of their selection trials and matches today

Pro Cricket Championship Trophy (PCCT) announced the schedule of their selection trials and matches today

May 26, 2022
Now our E-store India has become an international company

Now our E-store India has become an international company

November 1, 2022
Rotary announces: 20th Global Poster Painting Competition

Rotary announces: 20th Global Poster Painting Competition

June 8, 2022
On 27th & 28th December at Surat Marriott, Athwalines India’s premier fashion showcase Hi Life Exhibition is back

On 27th & 28th December at Surat Marriott, Athwalines India’s premier fashion showcase Hi Life Exhibition is back

December 26, 2023
Pro Cricket Championship Trophy (PCCT) announced the schedule of their selection trials and matches today

Pro Cricket Championship Trophy (PCCT) announced the schedule of their selection trials and matches today

27
MPF Investments are mainly aimed at companies in the Indian Market

MPF Investments are mainly aimed at companies in the Indian Market

4

TECNO launches SPARK Power 2 Air: The new Power Play Entertainment device

2

PrivateCourt is all set to revolutionize the concept of Online Dispute Resolution

1
Hemant Suresh Avhad – Winner of the 21st Century Emily Dickinson Award

Hemant Suresh Avhad – Winner of the 21st Century Emily Dickinson Award

May 30, 2025
Chander Parkash Malhotra – Winner of the 21st Century Emily Dickinson Award

Chander Parkash Malhotra – Winner of the 21st Century Emily Dickinson Award

May 29, 2025
Rajarshi Choudhury – Winner of the 21st Century Emily Dickinson Award

Rajarshi Choudhury – Winner of the 21st Century Emily Dickinson Award

May 28, 2025
Akarsha Alapati – Winner of the 21st Century Emily Dickinson Award

Akarsha Alapati – Winner of the 21st Century Emily Dickinson Award

May 28, 2025

Recent News

Hemant Suresh Avhad – Winner of the 21st Century Emily Dickinson Award

Hemant Suresh Avhad – Winner of the 21st Century Emily Dickinson Award

May 30, 2025
Chander Parkash Malhotra – Winner of the 21st Century Emily Dickinson Award

Chander Parkash Malhotra – Winner of the 21st Century Emily Dickinson Award

May 29, 2025
Rajarshi Choudhury – Winner of the 21st Century Emily Dickinson Award

Rajarshi Choudhury – Winner of the 21st Century Emily Dickinson Award

May 28, 2025
Akarsha Alapati – Winner of the 21st Century Emily Dickinson Award

Akarsha Alapati – Winner of the 21st Century Emily Dickinson Award

May 28, 2025

www.nationalage.com, digital news and story platform bring you the news, articles, stories, and opinions on the latest happenings worldwide covering various sectors like nation, politics, and governance, social sector, review, foreign affairs, defence and security, latest review, lifestyle, entertainment, sports, technology, auto sectors, education, business and start-ups updates, Agriculture, Science, finance, money, food, and culture, etc.

If you have any query regarding Site, Advertisement, and any other issue, please feel free to contact at [email protected]

Follow Us

Browse by Category

  • Agriculture
  • App News
  • Astrology
  • Auto
  • Business
  • Education
  • Entertainment
  • Fashion
  • Finance/Money
  • Food
  • Gadgets
  • Health & Fitness
  • Lifestyle
  • National
  • Photography
  • Politics
  • Press Release
  • Religion
  • Science
  • Social Work
  • Sports
  • State News
  • Tech
  • Travel
  • Uncategorized
  • World
Hemant Suresh Avhad – Winner of the 21st Century Emily Dickinson Award

Hemant Suresh Avhad – Winner of the 21st Century Emily Dickinson Award

May 30, 2025
Chander Parkash Malhotra – Winner of the 21st Century Emily Dickinson Award

Chander Parkash Malhotra – Winner of the 21st Century Emily Dickinson Award

May 29, 2025
Rajarshi Choudhury – Winner of the 21st Century Emily Dickinson Award

Rajarshi Choudhury – Winner of the 21st Century Emily Dickinson Award

May 28, 2025
  • About Us
  • Advertise
  • Contact Us
  • DMCA
  • Follow on Google News

Copyright © 2021 National Age

No Result
View All Result
  • About Us
  • Advertise
  • Contact Us
  • DMCA
  • Home
  • Privacy Policy

Copyright © 2021 National Age

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In